Skip to content
Saturday, November 14, 2026
Modern Play

Administering Pluripotent Cells During Pregnancy to Infants with Spina Bifida Improves Life Outcomes, Trial Finds

An innovative medical trial has discovered that delivering regenerative cells to unborn babies suffering from spina bifida during corrective surgery may represent a "important advancement" in treating birth defects.

Research Framework and Assurance

The research conducted in the United States examined six unborn babies with a severe neural tube defect. Doctors administered placenta-derived mesenchymal stem cells directly onto the infant's spine as part of the surgical correction.

Critically, the cell therapy was found to be safe. Researchers confirmed that the therapy did not induce cancerous growths, disrupt the healing process, or prevent the reversal of co-occurring hindbrain herniation.

Positive Developments

Imaging conducted after delivery showed a full resolution of hindbrain herniation in all six infants. This neurological improvement is closely linked to enhanced physical outcomes.

"Should it enable more children capable of walking who wouldn't have, it may emerge as the conventional approach," noted the study director. "These findings are super exciting and open the door to numerous possible new treatments."

Long-Term Prospects and Optimism

Experts not involved in the trial proposed that further confirmation of these noted improvements could announce a "different age" in prenatal intervention. The potential to improve neurological damage occurring during fetal development is considered a paradigm-shifting aim.

Notably important would be improvements in bladder and bowel function, which are typical difficulties for individuals living with this condition.

Looking Ahead

Despite this being a first-in-human effort involved a limited number of patients, its established security and encouraging indicators provide a strong foundation for larger, more comprehensive studies. The integration of stem cell therapy with established fetal surgery techniques offers substantial hope for changing life trajectories for babies yet to be born with myelomeningocele.

By

Kathryn Owens

A child psychologist and toy industry expert with over a decade of experience in early childhood education and product development.

Modern Play

Type to search articles.